Edition:
United Kingdom

Profile: Panacea Biotec Ltd (PNCA.NS)

PNCA.NS on National Stock Exchange of India

205.35INR
24 Apr 2019
Change (% chg)

Rs11.55 (+5.96%)
Prev Close
Rs193.80
Open
Rs193.50
Day's High
Rs208.80
Day's Low
Rs193.50
Volume
192,975
Avg. Vol
90,683
52-wk High
Rs301.00
52-wk Low
Rs137.75

Panacea Biotec Limited is a health management company. The Company's principal business activity is the manufacture of allopathic pharmaceuticals preparations. The Company's segments include Vaccines, Formulations, Research and Development; Healthcare and Real estate activities. Its Vaccines, Formulations and Research & Development segments are engaged in the business of research, development, manufacture and marketing of vaccines and branded pharmaceutical formulations. It has products for various segments, which include pediatric vaccines, pain management, diabetes management and organ transplantation. Its Healthcare segment is engaged in business of operating and maintaining hospitals. Its Real estate activities segment is engaged in the business of acquisition, construction and development of housing and commercial real estate projects. The Company's product portfolio includes prescription products in therapeutic areas, such as oncology, and nephrology and transplant management.

Company Address

Panacea Biotec Ltd

B-1 Extn / G-3
Mathura Road, Mohan Co-opIndlEst
NEW DELHI     110044
P: +9111.41679000
F: +9111.41679075

Company Web Links